Yu-Chi Lee

Years Active: 2019-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Luis Alejandro Zúñiga, Torben Leßmann, Karan Uppal, Nicola Bisek, Enping Hong, Caroline E Rasmussen, Jens-Jakob Karlsson, Joachim Zettler, Lars Holten-Andersen, Kathy Bang, Dhruv Thakar, Yu-Chi Lee, Salomon Martinez, Simran Singh Sabharwal, Sebastian Stark, Frank Faltinger, Oliver Kracker, Samuel Weisbrod, Robin Müller, Tobias Voigt, Kornelia Bigott, Mohammad Tabrizifard, Vibeke Miller Breinholt, Amer M Mirza, David B Rosen, Kennett Sprogøe, Juha Punnonen
Intratumoral delivery of TransCon ™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction. Cancer cell international 22 (1) (2022)
David Bauché, Barbara Joyce-Shaikh, Julie Fong, Alejandro V Villarino, Karin S Ku, Renu Jain, Yu-Chi Lee, Lakshmanan Annamalai, Jennifer H Yearley, Daniel J Cua
IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis. Science immunology 5 (46) (2020)
Govindarajan Thangavelu, Yu-Chi Lee, Michael Loschi, K Melanie Schaechter, Colby J Feser, Brent H Koehn, Elizabeth C Nowak, Robert Zeiser, Jonathan S Serody, William J Murphy, David H Munn, Pierre Chambon, Randolph J Noelle, Bruce R Blazar
Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality. Journal of immunology (Baltimore, Md. : 1950) 202 (9) (2019)

Yu-Chi Lee.css-eqlu8i{font-size:small;padding-left:4px;}